Hepatitis B virus (HBV) mutants unable to synthesize HBV e antigen have been described in association with fulminant hepatitis. We have cloned and sequenced the entire viral genome of an HBV strain associated with an epidemic of fulminant hepatitis. This strain contained, in addition to two G-to-A mutations in the precore region (nucleotides 1898 and 1901), numerous other mutations in conserved nucleotide positions resulting in significant amino acid substitutions in HBV gene products. We introduced either or both of the two G-to-A mutations into wild-type HBV by oligonucleotide-directed mutagenesis and generated replication-competent constructs of these mutants as well as the fulminant strain. Viral antigen synthesis, transcription, and replication were analyzed after transfection into human hepatoma cells. All viral constructs produced and secreted similar levels of envelope proteins (HBV surface antigen). Analysis of cellular lysate for core-specific immunoreactivity demonstrated a much higher level of core-associated antigens in cells transfected with the fulminant strain. While cells transfected with mutant and wild-type HBV DNAs synthesized similar levels of viral RNAs, the fulminant strain directed the synthesis of a much higher level of core-associated replicative intermediates (as well as virion particles) than the wild type and mutants with either or both of the precore mutations. Increase in the encapsidation of pregenomic RNA into core particles is likely the basis for the enhanced replication associated with the fulminant strain. Our study suggests that an HBV mutant with enhanced viral replication may be important in the pathogenesis of fulminant hepatic failure, and mutations other than the precore mutations may be responsible for this variant behavior.
Infection with hepatitis B virus (HBV) leads to a wide spectrum of liver injuries ranging from acute self-limited infection and fulminant hepatitis to chronic hepatitis with progression to cirrhosis and liver failure as well as to an asymptomatic chronic carrier state. There is accumulating evidence that HBV mutants unable to synthesize HBV e antigen (HBeAg) may influence the course of infection and clinical manifestations of disease (8, 10, 35) . Many mutations inactivating the precore reading frame which is necessary for the synthesis of HBeAg have been described (7, 11) . These mutations have been observed to arise de novo in patients chronically infected with wild-type HBV (38) . Acute infection with some of these mutants appears to be associated with fulminant hepatitis (28, 31, 39) . The pathogenesis of fulminant hepatitis B has been attributed to enhanced immune response against viral antigens (3, 47) .
We have previously described the association of an HBV variant containing two precore mutations with an epidemic of fulminant hepatitis B (31) . This nosocomial outbreak of five cases was remarkable for an unusually severe course of acute HBV infection leading to 100% mortality within a few days from hepatic and renal failure. The HBV strain responsible for this epidemic contained two G-to-A mutations in the precore open reading frame, one of them resulting in a stop codon. In this study, we cloned and sequenced the entire genome of this HBV strain and examined the viral antigen synthesis, transcription, and replication of this viral genome in transfected human hepatoma cells. In order to assess the biological effects of the two G-to-A mutations in the precore region, we introduced the mutations either separately or together into a wild-type HBV strain by oligonucleotide-directed mutagenesis and studied the biological properties of these mutants in vitro.
MATERIALS AND METHODS
HBV constructs. Serum DNA was purified from one of the patients with fulminant hepatitis B (patient 2) in the epidemic described previously (31) . Three overlapping fragments of the HBV genome were generated by PCR amplification with three sets of HBV primers. The three primer sets are: 5' ATTG CACCTGTATTCCCATCCCATC 3' (primer 1, sense, nucleotides [nt] 593 to 617) and 5' CGAGTCCAAGAGTCCTCT TAT (primer 2, antisense, nt 1656 to 1676), 5' TCTlFlCGG AGTGTGGATTCGCACTC 3' (primer 3, sense, nt 2263 to 2287) and 5' TAGGGTTlFAAATGTATACCCA 3' (primer 4, antisense, nt 823 to 843), and 5' TGGAATTCGCATGGA GACCA CCGTGAAC 3' (primer 5, sense, nt 1607 to 1627, with the underlined sequence indicating an EcoRI site) and 5' TCTGCGACGCGGCGATTGAGA 3' (primer 6, antisense, nt 2410 to 2430). The first PCR fragment was cloned into pGEM-5Zf(+) (Promega, Madison, Wis.), with an internal HBV restriction site of SpeI (nt 681) at one end and blunt-end ligation into the HincII site of the vector at the other end. The second fragment was cloned into pGEM-7Zf(+) with the internal HBV site of HindIII at one end (nt 2294) and blunt-end ligation into the SmaI site of the vector at the other end. The third fragment was generated by ligation of an internal HBV HinzdIII site (nt 2294) at one end and an EcoRI restriction site carried by primer 6 at the other end into pGEM-7Zf(+). A Terminally redundant genomes (1.2 times the genomic length) of two wild-type HBV strains were constructed. The construct containing an adw subtype which is replication competent after transfection into HuH-7 cells has been described previously (5) . The other was derived from an ayw subtype (21) which was a generous gift of H. Schaller (26, 43) and was constructed the same way as that of the adw subtype. A similar construct of the fulminant HBV strain (FH) with 1.2 times the genomic length was generated. While all the HBV constructs have theAatll site (nt 1417) at the 5' end, the 3' end of the FH construct was at nt 2294 (HindIII), as opposed to nt 2184 (DraI) in all other constructs. Since there was no DraI site at nt 2184 in the FH genome, the nearest restriction site, HindIll, was used instead. A schematic diagram of the constructs is shown in Fig. 1 .
Oligonucleotide mutagenesis. The Altered Sites in vitro mutagenesis system from Promega was used to generate three mutant HBV genomes with the precore mutations: one with a G-to-A mutation at nucleotide 1898 (MT1), the second with a G-to-A mutation at nucleotide position 1901 (MT2), and the third with both of the G-to-A mutations (MT3). The three mutant oligonucleotides are: 5' GGGTGGCTTTAGGGCAT GGACATT 3' (sense, nt 1888 to 1911), 5 (17) and analyzed by formaldehyde agarose gel electrophoresis and hybridized with an HBV-specific probe. Viral replicative intermediates associated with intracellular core particles were isolated by ultracentrifugation of cell lysate through a 30% sucrose cushion and then analyzed by Southern blot hybridization (5, 6) . Endogenous polymerase activity of the isolated core particles was analyzed as described previously (43) . Secreted viral particles were immunopurified by using anti-HBs(5D3)-coupled Sepharose (32). The washed beads were then subjected directly to endogenous polymerase activity analysis (43) . Secreted virions were first ultracentrifuged to form a pellet and then purified through a CsCl isopycnic centrifugation gradient (5, 6 transfection of HuH-7 cells with various HBV constructs, cells were lysed with RNA extraction buffer containing 10 mM Tris-HCl (pH 8.6), 0.14 M NaCl, 1.5 mM MgCl2, 1 mM dithiothreitol, 0.5% Nonidet P-40, and RNAsin (500 U/ml; Promega) on ice. After centrifugation to form a pellet of the nuclei, 10% of the supernatant was subjected to RNA isolation by the guanidinium isothiocyanate-acid-phenol method (17) . The remaining supernatant was subjected to ultracentrifugation to purify the core particles as described above. The pellet containing the core particles was treated with Staphylococcus aureus nuclease (Boehringer Mannheim, Indianapolis, Ind.) at a concentration of 8 ,ug/ml for 60 min at 37°C to eliminate any contaminating RNA and DNA. Core-associated RNA was then isolated. For primer extension analysis, an HBV primer (5' TCTAAGGCTlCTCGATACAGAGCTG 3') spanning nt 2006 to 2030 in the antisense orientation was end labelled with [y-32P]ATP and then reacted with isolated RNA by a standard protocol (1) . The products were analyzed on a 6% polyacrylamide-urea gel.
Nucleotide sequence accession number. The HBV nucleotide sequence has been entered into GenBank under accession number L27106.
RESULTS
Using three sets of PCR primers, we cloned the HBV genome from one of the patients with fulminant hepatitis B. The complete nucleotide sequence of this genome was obtained and is shown in Fig. 2 positions, 37 of which resulted in amino acid substitutions, were noted. Mutations were identified in all open reading frames: 12 in the precore/core region, 15 in the reverse transcriptase/polymerase region, 4 in the pre-S/surface region, and 6 in the X region (Table 1) .
A replication-competent construct of the mutant HBV genome was generated. Constructs of two distinct wild-type HBV strains, one adw and the other ayw subtype, were used as wild-type controls. Three HBV mutants with either or both G-to-A substitutions in the precore region (nt 1898 and 1901) generated by oligonucleotide-directed mutagenesis of the wildtype adw strain were constructed. All the HBV constructs contained 1.2 times the length of the HBV genome and spanned nt 1417 (AatII) to 2294 (HindIII) for the FH strain or to 2184 (DraI) for the others (Fig. 1) .
The HBV constructs were transfected into HuH-7 cells and assayed for the production of HBsAg and HBeAg. The results are shown in Table 2 . An hGH gene-containing plasmid (pTKGH) was cotransfected with each HBV construct to control for the transfection efficiency. The levels of HBsAg Fig. 3 . With controls for transfection efficiency, all the HBV constructs produced similar levels of Using a core antigen-specific ELISA system, we detected a significantly higher level of core antigen immunoreactivity in a lysate of cells transfected with the fulminant strain. In order to distinguish the possibilities of increased synthesis versus decreased turnover, metabolic labelling followed by immunoprecipitation using core-specific antibodies was performed. The results demonstrated that the rate of core antigen synthesis (p22) was similar among all the HBV constructs (Fig. 3) (Fig. 4) . The p22 core signal appears to be higher at time zero in the FH-transfected cells than that in the wild-type-transfected cells (absolute optical density of 6.098 versus 3.334 by densitometry). This discrepancy can be explained by a higher transfection efficiency in the FH-transfected cells in this experiment (about twice the hGH activities of the wild-type-transfected cells). Figure 4B illustrates the turnover of core proteins versus time by densitometric measurement of the autoradiogram. The results indicated that the newly synthesized FH cores appear to have a longer (about two times) intracellular half-life than the wild-type cores. These observations are consistent with our previous finding of a much higher level of core immunoreactivities in cells transfected with the FH strain than those transfected with other HBV strains. Cellular RNA was purified from each of the transfections and analyzed on Northern (RNA) gels for the synthesis of HBV transcripts (Fig. 5) . Two species of HBV RNA, 3.5 and 2.4 to 2.1 kb, were present at similar levels in all the transfected cells after correction for transfection efficiency and the amounts of RNA loaded on the gel.
HBV replication was then analyzed by Southern blot analysis of the replicative intermediates in the cell lysates (Fig. 6A) . The results showed clearly that the FH construct directed a much higher level of replicative intermediates than the wildtype HBV. All the site-directed mutants produced wild-type levels of replicative intermediates. Analysis of endogenous polymerase activity of purified core particles revealed similar findings (Fig. 6B) . These experiments have been repeated multiple times, and the results described above were consistently reproducible.
In order to demonstrate that Dane particle (matured virion) Increased HBV replication can be attributed to enhancement at any one of the various stages of the viral life cycle. The data presented so far have indicated an increase in all forms of replicative intermediates, from single-stranded DNA to partially double-stranded circular genomes. We surmise that the step which results in enhanced viral replication of the FH mutant occurs before or during the reverse transcription of HBV pregenomic RNA to viral DNA. Since most of the encapsidated pregenomic RNA is likely to be converted to DNA by reverse within the core particle, we reason that the step of encapsidation of pregenomic RNA is likely to be involved. In order to study the level of viral encapsidation, we isolated intracellular core particles, purified the encapsidated pregenomic RNA, and analyzed its level by primer extension analysis (Fig. 8) . Analysis of total RNA in cells transfected with various HBV constructs revealed three species of primer extension products, whereas only one major species was detected in reactions with the core-associated RNA. These observations are consistent with previous reports demonstrating that three species of mRNA with variable 5' ends are synthesized but only the shortest one is encapsidated (30, 52) . On one hand, the signals of primer-extended products of total RNA were comparable among all the HBV constructs, except that of the FH strain, which was weaker than the others. This difference was accounted for by a lower transfection efficiency of the FHtransfected cells in this experiment (approximately half as much hGH was produced). On the other hand, the signal generated by the core RNA in the FH-transfected cells was much more intense than the others, suggesting a much higher level of encapsidation of pregenomic RNA. Several smaller but significant species of extended products were seen preferentially in the FH-transfected samples. These probably represent strong stops of the primer extension reaction. In addition, we analyzed the total and core RNAs by RNase protection experiments. The results were comparable to those of the primer extension analysis and also demonstrated higher levels of encapsidated pregenomic RNA (data not shown).
DISCUSSION
In this study, we cloned and sequenced the entire viral genome of an HBV strain associated with an epidemic of fulminant hepatitis. Comparisons with all known published HBV sequences revealed mutations occurring at numerous conserved nucleotide positions. Multiple amino acid substitutions at conserved residues were present in all four open reading frames. It is interesting that mutations tended to cluster in the precore/core protein (Table 1) . Since core antigen has been postulated as the target of cell-mediated immunity (35) , it is tempting to speculate that these core mutations might contribute to a more severe course of disease, as suggested by a recent publication (19) . Two G-to-A mutations (nt 1898 Primer extension analysis of encapsidated viral RNA. Three days after transfection, total and core-associated RNAs (indicated by T and C, respectively, above the numbered lanes) were purified and subjected to primer extension analysis as described in Materials and Methods. Primer extension products were electrophoresed on a 6% polyacrylamide-urea gel and autoradiography using an intensifying screen with exposure time of 24 h at -80°C was performed. A dideoxy-sequencing reaction using the same primer on the adw strain is shown on the left (lanes marked A, G, C, and T). Lanes 1, 3, and 5, reactions with total RNA; lanes 2, 4, and 6, the core RNA.
1896 and 1901), it is conceivable that they alter the regulation of HBV transcription and replication by providing a thermodynamically stable stem-loop structure that was proposed to be the packaging signal for the encapsidation of HBV pregenomic RNA (22, 26) , resulting in an increase of -3.9 kcal/mol (- 16.3 kJ/mol) in Gibbs free energy (46) . In this study, we demonstrated that neither of these two mutations alone nor both together altered viral protein synthesis, transcription, or replication in transfected human hepatoma cells. Since these two precore mutations occur in the pregenomic RNA twice, it is necessary to exclude the possibility that mutations at these positions in the 3' end might be important. In order to address this issue, we generated three additional constructs with either or both mutations in both ends of the replication-competent genome and showed that these constructs were similar to their counterparts (MT1, MT2, and MT3) in transfection experiments (data not shown). Furthermore, in order to eliminate the possibility that the slightly longer construct of strain FH (110 bp longer than the other constructs at the 3' end) might be responsible for the enhanced replication, we generated two other terminally redundant constructs with their 3' ends at the BgllI site (nt 1984), one containing the ayw strain and the other containing the FH strain. The FH construct again demonstrated a much higher level of replication than the ayw construct (data not shown).
At present, we do not know whether these two precore mutations affect the life cycle of HBV in vivo. A woodchuck hepatitis virus mutant containing the same first precore mutation appeared to replicate normally in woodchucks (12) . Therefore, the absence of HBeAg production conferring a biological advantage during immune selection in infected hosts may indeed be the major reason for the emergence of these HBV precore mutants. Within the precore open reading frame, there are several possible codons which can be mutated to a stop codon resulting in the abrogation of HBeAg synthesis. Why the mutation occurs predominantly in the codon involving nt 1898 is not apparent. This could be explained by preferential VOL. 68, 1994 on November 7, 2017 by guest http://jvi.asm.org/ mutagenesis targeting this nucleotide during HBV replication. Since the precore region also contains direct repeat I and the encapsidation signal, mutations resulting in other potential stop codons may exert deleterious effects on the replication of HBV. Similar G-to-A mutation has been observed in the viral genome during replication of hepatitis delta virus in tissue cultures as well as in infected hosts (33) .
Our data demonstrated that increased encapsidation of viral pregenomic RNA was probably the basis for the observed enhanced viral replication in cells transfected with the FH strain. However, we cannot exclude the possibility that other mutations also contribute to the phenotype. Studies in other laboratories have shown that several components are required for the encapsidation of pregenomic RNA into HBV core particles (15, 23, 30) . The pregenomic RNA, the core protein, and the polymerase are essential for the completion of this process. By genetic analysis, the 5' region of polymerase, i.e., the terminal protein, is the important element for interaction with other components (2, 15) . However, a recent report described how a mutation in the 3' region of the duck HBV polymerase appeared to prevent encapsidation of the duck HBV genome (13) . A mutation(s) involving these components in the fulminant viral genome may contribute to a higher level of replicative intermediates observed in cells transfected with this viral DNA.
Although HBV is not thought to be cytopathic, it is conceivable that enhanced viral replication contributes to a more severe form of liver disease in several ways. First, during acute HBV infection, enhanced viral replication could result in an increased number of hepatocytes being infected, thus leading to more hepatocellular injury targeted by host immunocytes. Second, since core antigen has been proposed to be the target of the cell-mediated immune response (35) , increased core antigen accumulation in infected hepatocytes may contribute to a more vigorous immune response against the cells. In addition, several lines of evidence have suggested that dysregulated HBV gene expression can induce a cytopathic effect (16, 42, 53) . It is of interest that increased virulence of a viral strain has been attributed to enhanced viral replication in other viral systems as well (18, 25, 44) . At present, we have no direct indication that enhanced HBV replication is indeed the pathogenetic basis of fulminant hepatitis. The only indirect evidence supporting this notion is that this FH strain was transmitted from one patient to five other individuals, all of whom developed fulminant hepatitis. However, we cannot exclude other viral and/or host factors as important in the pathogenesis of fulminant hepatitis. In addition, our studies were limited to transfection experiments in tissue culture, which clearly does not reflect in vivo pathogenesis of HBV infection. To address this issue further, we need to study more cases of fulminant hepatitis B and develop an in vivo model to assess the biological significance of mutations identified by the above approach. Other hepadnaviruses, such as woodchuck hepatitis virus, will undoubtedly provide valuable models to address some of these issues.
